Abstract
South Africa is one of the countries heavily impacted by the COVID-19 pandemic. As of 9 January 2022, over 3.5 million confirmed cases of COVID-19 have been reported, and 93 551 deaths have been recorded in the country. The South African healthcare system faced a lack of essential resources and financial burdens by outbreaks and its new variant of concern (VOC), the Omicron. The local government has done as much as possible to control the spread of the virus in the local communities by quickly implementing lockdowns and enforcing movement restrictions. An eight-stage program to combat COVID-19 and a national vaccination strategy was also developed soon to manage the Coronavirus spread in the country better. As the country struggles to secure and administer COVID-19 vaccines to its people, the Coronavirus has been rapidly mutating and causing new waves of infections within the nation. The COVID-19 experience in South Africa demonstrates the great importance of equitable access to medicine, medical equipment, and vaccines globally. Equitable access to these essential resources is critical to prevent the virus spread across borders and reduce mortality rates worldwide.
Original language | English |
---|---|
Article number | a0000264 |
Journal | Progress in Microbes and Molecular Biology |
Volume | 5 |
Issue number | 1 |
DOIs | |
Publication status | Published - 2022 |
Externally published | Yes |
Keywords
- COVID-19
- South Africa
- coronavirus
- vaccination, pandemic
ASJC Scopus subject areas
- Microbiology
- Molecular Biology
- Biochemistry, Genetics and Molecular Biology (miscellaneous)
- Microbiology (medical)